Translating synthetic gene circuits into the clinic: Challenges, opportunities, and future directions
Cell Systems · 2025-12 · 16 (12) · 101425
DOI: 10.1016/j.cels.2025.101425 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cell Systems, 2025-12. Verfasst von Jianli Yin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Biomedical Synthetic Biology Research Centre, Shanghai Key Laboratory of Regula…. Hauptthemen laut MEDLINE: Gene Regulatory Networks, Genetic Therapy, Genes, Synthetic, Translational Research, Biomedical. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 150 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities, National Key Research and Development Program of China.
Abstract (Originalsprache)
Synthetic gene circuits represent a transformative approach in gene- and cell-based therapies, offering dynamic and precise control of therapeutic functions to address the limitations inherent in conventional treatments. Despite significant preclinical advancements, their clinical translation has been predominantly confined to relatively simple circuit designs, with few complex systems progressing into clinical trials. This perspective discusses current clinical applications of synthetic gene circuits, particularly their roles in solid tumor therapy, T cell-mediated immunomodulation, and metabolic disease management. We outline the therapeutic potential of these circuits and address the challenges impeding their clinical applications, including safety, specificity, immunogenicity, and delivery efficiency. To advance translation, we emphasize the importance of the development of humanized animal models, advanced delivery platforms, AI-driven optimization of circuit components, and the strategic selection of clinically target scenarios. Furthermore, we highlight emerging cybergenetics principles-intelligent and programmable genetic control systems-as a cornerstone for future smart living therapeutics and cell-based therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Biomedical Synthetic Biology Research Centre, Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Scie…
Förderung
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
- National Key Research and Development Program of China
- Science and Technology Commission of Shanghai Municipality
Zitieren
APA
Yin, J., Ma, X., Hu, L., & Ye, H. (2025). Translating synthetic gene circuits into the clinic: Challenges, opportunities, and future directions. Cell Systems, 16(12), 101425. https://doi.org/10.1016/j.cels.2025.101425
Vancouver
Yin J, Ma X, Hu L, Ye H. Translating synthetic gene circuits into the clinic: Challenges, opportunities, and future directions. Cell Systems. 2025;16(12):101425. doi:10.1016/j.cels.2025.101425
BibTeX
@article{Yin2025,
author = {Yin, Jianli and Ma, Xiaoding and Hu, Lingfeng and Ye, Haifeng},
title = {Translating synthetic gene circuits into the clinic: Challenges, opportunities, and future directions},
journal = {Cell Systems},
year = {2025},
volume = {16},
number = {12},
pages = {101425},
doi = {10.1016/j.cels.2025.101425}
}
EUVIMED